MMJ BioPharma Labs

MMJ BioPharma Labs is a specialized biotechnology company focused on the development of pharmaceutical-grade cannabinoid-derived medicines. The company operates a DEA-licensed facility dedicated to the extraction, formulation, and manufacturing of highly purified THC and CBD compounds for clinical research. Their lead clinical programs target neurodegenerative conditions, including Multiple Sclerosis and Huntington's Disease, utilizing proprietary liquid capsule formulations. MMJ BioPharma Labs distinguishes itself through its rigorous adherence to FDA and DEA regulatory standards for botanical drug development. By controlling the entire supply chain from cultivation to clinical trial supply, the company aims to provide standardized, evidence-based cannabinoid therapies to patients in need.